The need to accurately document novel coronavirus cases, manage vaccine administration, and analyze and share patient data, is critical to patients, their communities, and the healthcare professionals who serve them.
To support our healthcare partners and the entire HIT community, IMO is committed to delivering the most up-to-date terminology and insights solutions to help in the fight against this global pandemic.
*Requires IMO Core
**Available free of charge to IMO customers
***Available free of charge to non-IMO customers
Still wondering how IMO’s COVID-19 solutions can help your organization?
Our team is ready to answer any questions you may have. Ask away.
In creating not just one, but multiple, vaccines for the SARS-CoV-2 virus in under a year, pharmaceutical researchers and developers achieved a remarkable feat. But there’s still a challenge ahead: distributing and administering the vaccine across the country, while also managing a flood of inoculation data.
As vaccines for COVID-19 become more readily available, the possibility of getting back to life before the pandemic seems closer every day. That said, it’s still been over a year since the virus first appeared, requiring a slew of new terms and codes to describe not only the disease itself, but also adjacent tests, vaccines, and comorbidities. The following infographic shows how the industry and IMO responded to the clinical terminology needs of the past year.
At IMO, our employees are our greatest asset. So, it’s no surprise to us when we hear about the ways our fellow team members are working to enrich their communities. Marketing team member Jordan Leibovitz is just one of those recent examples. She’s inspiring us all through her work with the volunteer organization Vaccine Buddies, a Naperville-based group of individuals passionate about ensuring technology doesn’t limit access to the COVID-19 vaccine.
